Company intelligence / Profile preview

Ryme Medical

Mountain View, California, United Statesrymemedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Ryme Medical is developing a novel catheter-based device therapy targeting the autonomous nervous system to reduce symptoms and improve long-term outcomes in patients with COPD. The company has recently completed a Series A financing round to advance its technology through key clinical and regulatory milestones. No published human efficacy data or late-stage trial results are available as of June 2025

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Fogarty Innovation (MedTech incubator/advisor)Santé Ventures (investor/partner)Epidarex Capital (investor/partner)Seroba Life Sciences (investor/partner)

Beyond the preview

Go deeper on Ryme Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ryme Medical.

Explore the full profile